Studies of inflammation status in relation to vascular outcomes, using diagnostic tests ranging from leukocyte count determination to assessment of C-reactive protein (CRP) concentration, cellular adhesion molecules, and markers of plaque stability have progressed in recent years. Most recent attention has been on CRP; concentrations in the top third of the population are associated with an increased risk of approximately 50% for first future coronary and stroke events.1
Cushman M. Leukocyte Count in Vascular Risk Prediction. Arch Intern Med. 2005;165(5):487–488. doi:10.1001/archinte.165.5.487
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.